| Lightcalls.com |
|
|
![]() |
Dancing Mushroom. No, it's not the ...Dancing Mushroom. No, it's not the title of an off-Broadway play, moreover rather a translation of united of the names for a health-enhancing mushroom indigenous to Japan. The Maitake mushroom (Grifola frondosa) earned this moniker, according to myth because mushroom hunters danced with ravishment upon finding it growing wild. An expanding visible form [i]or[/i] frame of research shows that Maitake mushrooms do a apportionment more than simply inspire fancy footwork. Maitake may help the corpse steel itself against the onslaught of cancer and HIV/AIDS, supercharge the immune theory shrink painful fibroid cysts, give kindred vessels a break from rising life-blood pressure, and tip the scales toward the lower numbers, just to name hardly any of the possibilities. The active ingredient in medicinal mushrooms are polysaccharides called beta-glucans. The Maitake mushroom contains a unique beta-glucan, called D-fraction, that settles it apart as a health elixir. This D-fraction is believed to be responsible for the many health benefits of Maitake. The majority of research escorted regarding the Maitake mushroom has center in succession cancer prevention. Although Maitake isn't believed to kill cancer confined apartments directly, it does protect the material part from cancer by stimulating the immune enclosed spaces that, in turn, fight facing cancerous cells. Some experts believe that Maitake may help inhibit tumors that are already growing, obviate the initiation of new cancers, and stop (or at least inactive down) the severe secondary symptoms associated with cancer. Help for chemotherapy and fibroids Maitake can also provide welcome relief to cancer patients undergoing chemotherapy. undivided of the side effects of chemotherapy is impaired immune function, since anti-cancer put drugs intos tend to knock out everything in their path, including a certain number of innocent immune system bystanders. Therefore, taking this extract of Maitake in conjunction with chemotherapy may breed increased benefits while making the treatment easier for the patient to endure In fact, a non-randomized clinical reflection on advanced cancer patients in Japan showed that taking D-fraction and Maitake tablets, in conjunction with chemotherapy, prov to be particularly helpful in women with breast cancer. Of the 15 breast-cancer patients in the trial, 867 percent of them rejoined favorably in parameters such as tumor size, improved kindred tests, and quality-of-life factors like as a reduction in vomiting and an increased appetite. bodily forms with lung and liver cancers also reported significantly favorable answer rates of 75 and 733 percent respectively. Abram Ber, MD a homeopathic physician practicing orthomolecular medicine in Scottsdale, Ariz., has used Maitake fill ups in his practice for quite more [i]or[/i] less time. One area that impresses Ber is Maitake's ability to actually shrink fibroids in the uterus. Many of Ber's patients, after taking Maitake add tos for six months to individual year, showed such an improvement in the size of their fibroids that surgery was counted unnecessary. have the direction of high blood pressure with Maitake High offspring pressure is another condition benefited through Maitake. Ber has used Maitake, with reportedly beneficial results, in patients with high vital current pressure. "When on medication, the life-blood pressure is all over the place, moreover with Maitake mushrooms, there is a gradual decrease in kindred pressure toward normalcy. Further, there are absolutely no side effects" Ber explained. Maitake may equal be able to help those facing an expanding waistband. For starters -- as with other mushrooms -- Maitake is subdued in calories while packing in destinys of vitamins and minerals. united study from Japan reports that Maitake postscripts can significantly increase weight los In this studious mood 30 overweight patients took daily correlatives of Maitake for two month without making any other dietary or lifestyle changes. After just eight weeks of taking the Maitake appendixs each patient lost an average of 11 to 13 impounds with some patients losing as to a great degree as 25 pounds. These weight-loss ensues are amazing considering the short time period of the close attention and the fact that no other dieting modes were employed. REFERENCES Cichoke, A.J. "Maitake: The King of Mushrooms," Townsend literal sense for Doctors 432433, May 1994 Nanba, Hiroaki. "Result of Non-Controlled Clinical consideration for Various Cancer Patients Using Maitake D-Fraction," Explore! (6)5 1995 Schechter, SR "Maitake, the Magic Mushroom," The Natural Way 82:22-23 February/March 1995 COPYRIGHT 1997 PRIMEDIA Intertec, a PRIMEDIA Company. All Rights Reserved |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |